APO Research
Talk to an analyst

APO RESEARCH · REPORT

Calming and Sleeping

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Calming and Sleeping Market Outlook and Growth Opportunities 2026

20 December 2025194 pages

Choose your research edition.

Industry ResearchCalming and Sleeping Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Calming and Sleeping Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Calming and Sleeping Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Calming and Sleeping Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Calming and Sleeping Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Calming and Sleeping market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Calming and Sleeping market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Calming and Sleeping market include Teva Pharmaceutical, Johnson & Johnson, Eli Lilly, AstraZeneca, Sunovion Pharmaceuticals, Roscoe Medical, Durect, Collegium Pharmaceutical and Cara Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Calming and Sleeping market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Calming and Sleeping and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Calming and Sleeping sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Calming and Sleeping market size, projected growth trends, production technologies, key applications, and end-use industries.

Calming and Sleeping Segment by Company

Teva Pharmaceutical

Johnson & Johnson

Eli Lilly

AstraZeneca

Sunovion Pharmaceuticals

Roscoe Medical

Durect

Collegium Pharmaceutical

Cara Therapeutics

Acura Pharmaceuticals

Calming and Sleeping Segment by Type

Medications

Sleep Laboratories

Sleep Apnea Devices

Mattresses and Pillows

Prescriptions

Over-The-Counter (OTC)

Calming and Sleeping Segment by Application

Restless Leg Syndrome (RLS)

Narcolepsy

Sleepwalking

Bruxism

Insomnia

Sleep apnea

Calming and Sleeping Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Calming and Sleeping status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Calming and Sleeping market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Calming and Sleeping significant trends, drivers, influence factors in global and regions.

6. To analyze Calming and Sleeping competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming and Sleeping market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Calming and Sleeping and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming and Sleeping.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Calming and Sleeping market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Calming and Sleeping industry.

Chapter 3: Detailed analysis of Calming and Sleeping manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Calming and Sleeping in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Calming and Sleeping in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Calming and Sleeping Industry Trends Table 2. Calming and Sleeping Industry Drivers Table 3. Calming and Sleeping Industry Opportunities and Challenges Table 4. Calming and Sleeping Industry Restraints Table 5. Global Calming and Sleeping Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Calming and Sleeping Revenue Share by Company (2021-2026) Table 7. Global Calming and Sleeping Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Calming and Sleeping Sales Volume Share by Company (2021-2026) Table 9. Global Calming and Sleeping Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Calming and Sleeping Company Ranking, (2024-2026) & (USD Million) Table 11. Global Calming and Sleeping Key Company Manufacturing Base & Headquarters Table 12. Global Calming and Sleeping Company, Product Type & Application Table 13. Global Calming and Sleeping Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Calming and Sleeping by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Medications Table 18. Significant Companies of Sleep Laboratories Table 19. Significant Companies of Sleep Apnea Devices Table 20. Significant Companies of Mattresses and Pillows Table 21. Significant Companies of Prescriptions Table 22. Significant Companies of Over-The-Counter (OTC) Table 23. Global Calming and Sleeping Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Calming and Sleeping Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Calming and Sleeping Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Calming and Sleeping Sales Volume Share by Type (2021-2026) Table 27. Global Calming and Sleeping Sales Volume Share by Type (2027-2032) Table 28. Global Calming and Sleeping Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Calming and Sleeping Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Calming and Sleeping Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Calming and Sleeping Sales Value Share by Type (2021-2026) Table 32. Global Calming and Sleeping Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Restless Leg Syndrome (RLS) Table 34. Significant Companies of Narcolepsy Table 35. Significant Companies of Sleepwalking Table 36. Significant Companies of Bruxism Table 37. Significant Companies of Insomnia Table 38. Significant Companies of Sleep apnea Table 39. Global Calming and Sleeping Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Calming and Sleeping Sales Volume by Application (2021-2026) & (K Units) Table 41. Global Calming and Sleeping Sales Volume by Application (2027-2032) & (K Units) Table 42. Global Calming and Sleeping Sales Volume Share by Application (2021-2026) Table 43. Global Calming and Sleeping Sales Volume Share by Application (2027-2032) Table 44. Global Calming and Sleeping Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Calming and Sleeping Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Calming and Sleeping Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Calming and Sleeping Sales Value Share by Application (2021-2026) Table 48. Global Calming and Sleeping Sales Value Share by Application (2027-2032) Table 49. Global Calming and Sleeping Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 50. Global Calming and Sleeping Sales by Region (2021-2026) & (K Units) Table 51. Global Calming and Sleeping Sales Market Share by Region (2021-2026) Table 52. Global Calming and Sleeping Sales by Region (2027-2032) & (K Units) Table 53. Global Calming and Sleeping Sales Market Share by Region (2027-2032) Table 54. Global Calming and Sleeping Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Calming and Sleeping Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Calming and Sleeping Sales Value Share by Region (2021-2026) Table 57. Global Calming and Sleeping Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Calming and Sleeping Sales Value Share by Region (2027-2032) Table 59. Global Calming and Sleeping Market Average Price (US$/Unit) by Region (2021-2026) Table 60. Global Calming and Sleeping Market Average Price (US$/Unit) by Region (2027-2032) Table 61. Global Calming and Sleeping Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. Global Calming and Sleeping Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Calming and Sleeping Sales by Country (2021-2026) & (K Units) Table 64. Global Calming and Sleeping Sales Market Share by Country (2021-2026) Table 65. Global Calming and Sleeping Sales by Country (2027-2032) & (K Units) Table 66. Global Calming and Sleeping Sales Market Share by Country (2027-2032) Table 67. Global Calming and Sleeping Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Calming and Sleeping Sales Value Market Share by Country (2021-2026) Table 69. Global Calming and Sleeping Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Calming and Sleeping Sales Value Market Share by Country (2027-2032) Table 71. Teva Pharmaceutical Company Information Table 72. Teva Pharmaceutical Business Overview Table 73. Teva Pharmaceutical Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical Calming and Sleeping Product Portfolio Table 75. Teva Pharmaceutical Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Johnson & Johnson Calming and Sleeping Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eli Lilly Calming and Sleeping Product Portfolio Table 85. Eli Lilly Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. AstraZeneca Calming and Sleeping Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Sunovion Pharmaceuticals Company Information Table 92. Sunovion Pharmaceuticals Business Overview Table 93. Sunovion Pharmaceuticals Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sunovion Pharmaceuticals Calming and Sleeping Product Portfolio Table 95. Sunovion Pharmaceuticals Recent Development Table 96. Roscoe Medical Company Information Table 97. Roscoe Medical Business Overview Table 98. Roscoe Medical Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Roscoe Medical Calming and Sleeping Product Portfolio Table 100. Roscoe Medical Recent Development Table 101. Durect Company Information Table 102. Durect Business Overview Table 103. Durect Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Durect Calming and Sleeping Product Portfolio Table 105. Durect Recent Development Table 106. Collegium Pharmaceutical Company Information Table 107. Collegium Pharmaceutical Business Overview Table 108. Collegium Pharmaceutical Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Collegium Pharmaceutical Calming and Sleeping Product Portfolio Table 110. Collegium Pharmaceutical Recent Development Table 111. Cara Therapeutics Company Information Table 112. Cara Therapeutics Business Overview Table 113. Cara Therapeutics Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Cara Therapeutics Calming and Sleeping Product Portfolio Table 115. Cara Therapeutics Recent Development Table 116. Acura Pharmaceuticals Company Information Table 117. Acura Pharmaceuticals Business Overview Table 118. Acura Pharmaceuticals Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Acura Pharmaceuticals Calming and Sleeping Product Portfolio Table 120. Acura Pharmaceuticals Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Calming and Sleeping Distributors List Table 124. Calming and Sleeping Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Calming and Sleeping Product Image Figure 2. Global Calming and Sleeping Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Calming and Sleeping Sales Value (2021-2032) & (US$ Million) Figure 4. Global Calming and Sleeping Sales (2021-2032) & (K Units) Figure 5. Global Calming and Sleeping Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Calming and Sleeping Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Medications Image Figure 10. Sleep Laboratories Image Figure 11. Sleep Apnea Devices Image Figure 12. Mattresses and Pillows Image Figure 13. Prescriptions Image Figure 14. Over-The-Counter (OTC) Image Figure 15. Global Calming and Sleeping Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Calming and Sleeping Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Calming and Sleeping Sales Volume Share by Type (2021-2032) Figure 18. Global Calming and Sleeping Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Calming and Sleeping Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Calming and Sleeping Sales Value Share by Type (2021-2032) Figure 21. Restless Leg Syndrome (RLS) Image Figure 22. Narcolepsy Image Figure 23. Sleepwalking Image Figure 24. Bruxism Image Figure 25. Insomnia Image Figure 26. Sleep apnea Image Figure 27. Global Calming and Sleeping Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Calming and Sleeping Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Calming and Sleeping Sales Volume Share by Application (2021-2032) Figure 30. Global Calming and Sleeping Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Calming and Sleeping Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Calming and Sleeping Sales Value Share by Application (2021-2032) Figure 33. Global Calming and Sleeping Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 34. Global Calming and Sleeping Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Calming and Sleeping Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Calming and Sleeping Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Calming and Sleeping Sales Value (2021-2032) & (US$ Million) Figure 38. North America Calming and Sleeping Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Calming and Sleeping Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Calming and Sleeping Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Calming and Sleeping Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Calming and Sleeping Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Calming and Sleeping Sales Value (2021-2032) & (US$ Million) Figure 44. South America Calming and Sleeping Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Calming and Sleeping Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Calming and Sleeping Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Calming and Sleeping Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Calming and Sleeping Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Calming and Sleeping Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Calming and Sleeping Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Calming and Sleeping Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • Medications
  • Sleep Laboratories
  • Sleep Apnea Devices
  • Mattresses and Pillows
  • Prescriptions
  • Over-The-Counter (OTC)
Applications
  • Restless Leg Syndrome (RLS)
  • Narcolepsy
  • Sleepwalking
  • Bruxism
  • Insomnia
  • Sleep apnea
Companies covered
  • Teva Pharmaceutical
  • Johnson & Johnson
  • Eli Lilly
  • AstraZeneca
  • Sunovion Pharmaceuticals
  • Roscoe Medical
  • Durect
  • Collegium Pharmaceutical
  • Cara Therapeutics
  • Acura Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Calming and Sleeping Sales Value (2021-2032)
  4. 1.2.2 Global Calming and Sleeping Sales Volume (2021-2032)
  5. 1.2.3 Global Calming and Sleeping Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Calming and Sleeping Market Dynamics
  1. 2.1 Calming and Sleeping Industry Trends
  2. 2.2 Calming and Sleeping Industry Drivers
  3. 2.3 Calming and Sleeping Industry Opportunities and Challenges
  4. 2.4 Calming and Sleeping Industry Restraints
3 Calming and Sleeping Market by Company
  1. 3.1 Global Calming and Sleeping Company Revenue Ranking in 2025
  2. 3.2 Global Calming and Sleeping Revenue by Company (2021-2026)
  3. 3.3 Global Calming and Sleeping Sales Volume by Company (2021-2026)
  4. 3.4 Global Calming and Sleeping Average Price by Company (2021-2026)
  5. 3.5 Global Calming and Sleeping Company Ranking (2024-2026)
  6. 3.6 Global Calming and Sleeping Company Manufacturing Base and Headquarters
  7. 3.7 Global Calming and Sleeping Company Product Type and Application
  8. 3.8 Global Calming and Sleeping Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Calming and Sleeping Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Calming and Sleeping Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Calming and Sleeping Market by Type
  1. 4.1 Calming and Sleeping Type Introduction
  2. 4.1.1 Medications
  3. 4.1.2 Sleep Laboratories
  4. 4.1.3 Sleep Apnea Devices
  5. 4.1.4 Mattresses and Pillows
  6. 4.1.5 Prescriptions
  7. 4.1.6 Over-The-Counter (OTC)
  8. 4.2 Global Calming and Sleeping Sales Volume by Type
  9. 4.2.1 Global Calming and Sleeping Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Calming and Sleeping Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Calming and Sleeping Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Calming and Sleeping Sales Value by Type
  13. 4.3.1 Global Calming and Sleeping Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Calming and Sleeping Sales Value by Type (2021-2032)
  15. 4.3.3 Global Calming and Sleeping Sales Value Share by Type (2021-2032)
5 Calming and Sleeping Market by Application
  1. 5.1 Calming and Sleeping Application Introduction
  2. 5.1.1 Restless Leg Syndrome (RLS)
  3. 5.1.2 Narcolepsy
  4. 5.1.3 Sleepwalking
  5. 5.1.4 Bruxism
  6. 5.1.5 Insomnia
  7. 5.1.6 Sleep apnea
  8. 5.2 Global Calming and Sleeping Sales Volume by Application
  9. 5.2.1 Global Calming and Sleeping Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Calming and Sleeping Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Calming and Sleeping Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Calming and Sleeping Sales Value by Application
  13. 5.3.1 Global Calming and Sleeping Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Calming and Sleeping Sales Value by Application (2021-2032)
  15. 5.3.3 Global Calming and Sleeping Sales Value Share by Application (2021-2032)
6 Calming and Sleeping Regional Sales and Value Analysis
  1. 6.1 Global Calming and Sleeping Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Calming and Sleeping Sales by Region (2021-2032)
  3. 6.2.1 Global Calming and Sleeping Sales by Region: 2021-2026
  4. 6.2.2 Global Calming and Sleeping Sales by Region (2027-2032)
  5. 6.3 Global Calming and Sleeping Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Calming and Sleeping Sales Value by Region (2021-2032)
  7. 6.4.1 Global Calming and Sleeping Sales Value by Region: 2021-2026
  8. 6.4.2 Global Calming and Sleeping Sales Value by Region (2027-2032)
  9. 6.5 Global Calming and Sleeping Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Calming and Sleeping Sales Value (2021-2032)
  12. 6.6.2 North America Calming and Sleeping Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Calming and Sleeping Sales Value (2021-2032)
  15. 6.7.2 Europe Calming and Sleeping Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Calming and Sleeping Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Calming and Sleeping Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Calming and Sleeping Sales Value (2021-2032)
  21. 6.9.2 South America Calming and Sleeping Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Calming and Sleeping Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Calming and Sleeping Sales Value Share by Country, 2025 VS 2032
7 Calming and Sleeping Country-level Sales and Value Analysis
  1. 7.1 Global Calming and Sleeping Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Calming and Sleeping Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Calming and Sleeping Sales by Country (2021-2032)
  4. 7.3.1 Global Calming and Sleeping Sales by Country (2021-2026)
  5. 7.3.2 Global Calming and Sleeping Sales by Country (2027-2032)
  6. 7.4 Global Calming and Sleeping Sales Value by Country (2021-2032)
  7. 7.4.1 Global Calming and Sleeping Sales Value by Country (2021-2026)
  8. 7.4.2 Global Calming and Sleeping Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Calming and Sleeping Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Calming and Sleeping Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Calming and Sleeping Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Calming and Sleeping Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Calming and Sleeping Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Calming and Sleeping Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Calming and Sleeping Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Calming and Sleeping Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Calming and Sleeping Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Calming and Sleeping Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Calming and Sleeping Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Calming and Sleeping Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Calming and Sleeping Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Calming and Sleeping Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Calming and Sleeping Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Calming and Sleeping Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Calming and Sleeping Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Calming and Sleeping Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Calming and Sleeping Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Calming and Sleeping Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Calming and Sleeping Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Calming and Sleeping Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Calming and Sleeping Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Calming and Sleeping Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Calming and Sleeping Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Calming and Sleeping Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Calming and Sleeping Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Calming and Sleeping Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Calming and Sleeping Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Calming and Sleeping Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Calming and Sleeping Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Calming and Sleeping Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Calming and Sleeping Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Calming and Sleeping Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Calming and Sleeping Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Calming and Sleeping Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Calming and Sleeping Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Calming and Sleeping Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Sunovion Pharmaceuticals
  26. 8.5.1 Sunovion Pharmaceuticals Company Information
  27. 8.5.2 Sunovion Pharmaceuticals Business Overview
  28. 8.5.3 Sunovion Pharmaceuticals Calming and Sleeping Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sunovion Pharmaceuticals Calming and Sleeping Product Portfolio
  30. 8.5.5 Sunovion Pharmaceuticals Recent Developments
  31. 8.6 Roscoe Medical
  32. 8.6.1 Roscoe Medical Company Information
  33. 8.6.2 Roscoe Medical Business Overview
  34. 8.6.3 Roscoe Medical Calming and Sleeping Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Roscoe Medical Calming and Sleeping Product Portfolio
  36. 8.6.5 Roscoe Medical Recent Developments
  37. 8.7 Durect
  38. 8.7.1 Durect Company Information
  39. 8.7.2 Durect Business Overview
  40. 8.7.3 Durect Calming and Sleeping Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Durect Calming and Sleeping Product Portfolio
  42. 8.7.5 Durect Recent Developments
  43. 8.8 Collegium Pharmaceutical
  44. 8.8.1 Collegium Pharmaceutical Company Information
  45. 8.8.2 Collegium Pharmaceutical Business Overview
  46. 8.8.3 Collegium Pharmaceutical Calming and Sleeping Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Collegium Pharmaceutical Calming and Sleeping Product Portfolio
  48. 8.8.5 Collegium Pharmaceutical Recent Developments
  49. 8.9 Cara Therapeutics
  50. 8.9.1 Cara Therapeutics Company Information
  51. 8.9.2 Cara Therapeutics Business Overview
  52. 8.9.3 Cara Therapeutics Calming and Sleeping Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cara Therapeutics Calming and Sleeping Product Portfolio
  54. 8.9.5 Cara Therapeutics Recent Developments
  55. 8.10 Acura Pharmaceuticals
  56. 8.10.1 Acura Pharmaceuticals Company Information
  57. 8.10.2 Acura Pharmaceuticals Business Overview
  58. 8.10.3 Acura Pharmaceuticals Calming and Sleeping Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Acura Pharmaceuticals Calming and Sleeping Product Portfolio
  60. 8.10.5 Acura Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Calming and Sleeping Value Chain Analysis
  2. 9.1.1 Calming and Sleeping Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Calming and Sleeping Sales Mode & Process
  6. 9.2 Calming and Sleeping Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Calming and Sleeping Distributors
  9. 9.2.3 Calming and Sleeping Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst